glp-1 novo nordisk products Healthy Returns: A key step forward for Nordisk's pill Novo Nordisk hikes full-year forecast

10.1155/2013/781348 9 FelkerD.LynnA.WangS.JohnsonD

The agency also identified an unresolved carcinogenicity concern arising from reported telomerase activation and telomere extension

What the Research Shows The approval was based on impressive results from the SURMOUNT-OSA clinical trials involving 469 adults: For people NOT using CPAP machines: Tirzepatide reduced breathing interruptions by 25 events per hour Placebo only reduced interruptions by 5 events per hour 42% achieved remission or mild symptoms after one year For people USING CPAP machines: Tirzepatide reduced breathing interruptions by 29 events per hour Placebo only reduced interruptions by 6 events per hour 50% achieved remission or mild symptoms after one year Beyond Sleep Apnea While sleep apnea research is most advanced, early evidence suggests GLP-1 medications may help with other sleep problems too: Reduced insomnia symptoms Less tossing and turning at night Improved deep sleep quality Better daytime energy levels Who Can Benefit From GLP-1 Therapy for Sleep

GLP-1RAs , (AS), , .16,17,18,19 GLP-1 ,

202103021223219 and 20210302124584), FSKSC, and 1331KSC